CELL INTELLIGENCE · 肿瘤细胞治疗研究

下一代基于抗体的癌症治疗：抗体-药物偶联物和双特异性抗体在血液系统恶性肿瘤和实体瘤中的应用

Next-generation antibody-based therapeutics in cancer: antibody-drug conjugates bispecific antibodies across hematologic malignancies and solid tumors

结直肠癌和浸润性乳腺癌中 CAR-T 细胞治疗的临床新视角与挑战

Updated Clinical Perspectives and Challenges of Chimeric Antigen Receptor-T Cell Therapy in Colorectal Cancer and Invasive Breast Cancer.

胰岛素样生长因子 2 受体是三阴性乳腺癌患者预后不良相关的关键免疫相关基因：一项生物信息学分析

Insulin-like growth factor 2 receptor is a key immune-related gene that is correlated with a poor prognosis in patients with triple-negative breast ca

IGF2R 可作为 TNBC 患者预后不良的指标，并可作为未来 TNBC 免疫治疗的潜在靶点和研究方向。